DiaMedica Therapeutics: Preeclampsia Program to Be Initiated With a Phase 2 Investigator-Sponsored Trial Beginning in Q4 2024
diamedica therapeutics: 明礬水毒症項目將於2024年第4季度開始進行2期調查員發起的試驗。
DiaMedica Therapeutics: Preeclampsia Program to Be Initiated With a Phase 2 Investigator-Sponsored Trial Beginning in Q4 2024
diamedica therapeutics: 明礬水毒症項目將於2024年第4季度開始進行2期調查員發起的試驗。
譯文內容由第三人軟體翻譯。